Apto stock future

22 Mar 2020 Real-time trade and investing ideas on Aptose Biosciences Inc APTO $APTO WOW futures are crashing, not looking good for small cap bios. Based on 6 analysts offering 12 month price targets for Aptose Biosciences in the last 3 months. The average price target is $11.33 with a high forecast of $16.00  Get today's Aptose Biosciences Inc stock price and latest APS news as well as Aptose Are Options Traders Betting On A Big Move In Aptose (APTO) Stock? U.S. Commodity Futures Trading Commission (United States), Securities and 

APTO Stock Risk. This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to  View APTO's stock price, price target, earnings, financials, forecast, insider trades , unlikely to have an impact on the stock's share price in the immediate future. Performance Outlook. Short Term. 2W - 6W · Mid Term. 22 Mar 2020 Real-time trade and investing ideas on Aptose Biosciences Inc APTO $APTO WOW futures are crashing, not looking good for small cap bios. Based on 6 analysts offering 12 month price targets for Aptose Biosciences in the last 3 months. The average price target is $11.33 with a high forecast of $16.00  Get today's Aptose Biosciences Inc stock price and latest APS news as well as Aptose Are Options Traders Betting On A Big Move In Aptose (APTO) Stock? U.S. Commodity Futures Trading Commission (United States), Securities and  Aptose Biosciences (NASDAQ: APTO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and 

Feb 21, 2020 · Investors in Aptose Biosciences Inc. APTO need to pay close attention to the stock based on moves in the options market lately. That is because …

APTO | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for APTOSE BIOSCIENCES INC (APTO), including profile, stock chart, recent news and events, analyst opinions, and research reports. Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Is The Options Market Predicting A Spike In Aptose (APTO ... Investors in Aptose Biosciences Inc. (NASDAQ: APTO) need to pay close attention to the stock based on moves in the options market lately.That is because the Apr 17, 2020 $5.00 Put had some of the Aptose Biosciences, Inc. (APTO) Stock Message Board ... Mar 15, 2020 · On 6/8/2017, the company got rated as neutral by Rodman & Renshaw. Also, analysts rated the stock as a buy with a price target of $9. In forward-looking thoughts, $9 is a very optimistic number to put on a stock that currently doesn’t have any income, and is relying solely on investors. Is the Options Market Predicting a Spike in Aptose (APTO ...

Here’s The Case for and Against Aptose Biosciences Inc. (APTO)

Get breaking news and analysis on Aptose Biosciences Inc. (APTO) stock, price quote and chart, trading and investing tools. Careers at Apto "The greatest part of working for Apto is the respect and trust that I have for my coworkers - it allows for greater collaboration on projects and makes the time at I spend at work all the more enjoyable."

On Friday, shares of Aptose Biosciences Inc. (NASDAQ:APTO) marked $8.65 per share versus a previous $9.00 closing price. With having a -3.89% loss, an insight into the fundamental values of Aptose Biosciences Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

Mar 15, 2020 · On 6/8/2017, the company got rated as neutral by Rodman & Renshaw. Also, analysts rated the stock as a buy with a price target of $9. In forward-looking thoughts, $9 is a very optimistic number to put on a stock that currently doesn’t have any income, and is relying solely on investors. Is the Options Market Predicting a Spike in Aptose (APTO ...

APTO | Aptose Biosciences Inc. Profile | MarketWatch

Aptose Biosciences to Host Key Opinion Leader Event ... Jan 29, 2020 · SAN DIEGO and TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the company will host a key opinion leader (KOL) event on Wednesday, February 5th, 2020 in New York City. APTO - Aptose Biosciences Inc Stock quote - CNNMoney.com Find real-time APTO - Aptose Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. Is the Options Market Predicting a Spike in Aptose (APTO ... Investors in Aptose Biosciences Inc. (APTO - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Apr 17, 2020 $5.00 Put had some

At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Aptose Biosciences Inc (APTO). If you are looking for  Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Aptose Biosciences Inc have a median target of 10.00, with a high estimate of 16.00  APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview.